by GlobeNewsWire | Jun 13, 2016 | Feature Box, Featured, FP, Globe Newswire
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment...